Ondansetron
- Product NDC
- 0409-0009
- 11-digit product format
- 004090009
- Labeler code
- 0409
- Product ID
- 0409-0009_2c782e5a-aea8-423f-864d-40dcdb7f5864
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ONDANSETRON
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Hospira, Inc.
- Application
- ANDA077548
- Marketing category
- ANDA
- Marketing start
- 2024-12-16
- Substance
- ONDANSETRON HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077548-001 | ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | ONDANSETRON HYDROCHLORIDE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2006-12-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077548-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077548-001 | ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2006-12-26 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077548-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron | ONDANSETRON | Cardinal Health 107, LLC | 1b9c2d9f-62a8-4d26-a041-a598bc59e300 | 2026-06-26 | Warnings, Adverse reactions | 077548 ANDA077548 |
| Ondansetron | ONDANSETRON | Hospira, Inc. | d62cd60b-f87e-4825-bead-1d18bbc4e480 | 2026-05-23 | Warnings, Adverse reactions | 077548 ANDA077548 0409-0009 |
| Ondansetron | ONDANSETRON | Hospira, Inc. | 6a11f61b-2318-4382-2b91-4366e4bb53fa | 2026-05-22 | Warnings, Adverse reactions | 077548 ANDA077548 |
| Ondansetron | ONDANSETRON | Hospira, Inc. | e0862c02-781f-4b10-ae50-9c9c4ca26f6d | 2025-12-01 | Warnings, Adverse reactions | 077548 ANDA077548 |
| ONDANSETRON | ONDANSETRON | HF Acquisition Co LLC, DBA HealthFirst | 99ac0a5e-dd2a-4352-e053-2a95a90a68fd | 2025-01-08 | Warnings, Adverse reactions | 077548 ANDA077548 |
| Ondansetron | ONDANSETRON | Medical Purchasing Solutions, LLC | 89698ef8-62d3-77e4-e053-2995a90ab9db | 2023-05-15 | Warnings, Adverse reactions | 077548 ANDA077548 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ondansetron
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ONDANSETRON HYDROCHLORIDE | 2 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| NMH84OZK2B | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1740467 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| d62cd60b-f87e-4825-bead-1d18bbc4e480 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d9bd4853-037c-6968-f4d4-9bb9a0efd1ea | Product name | 2 | 20250722 |
| 32e23bc9-ce14-4555-bb6d-bcb654d7d296 | Product name | 1 | 20201015 |
| e459f50a-1553-4aab-b6bd-1e5f0c211c49 | Product name | 1 | 20201015 |
| 909480fe-0d18-c1c1-a658-0bd9a7131822 | Product name | 5 | 20170829 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-0009-02 | Ondansetron | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 4 | |
| 0409-0009-25 | Ondansetron | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-0009-02 | ML - Milliliter | 0409-0009 | 982635e2-7b68-47b2-b305-6c820e9d3fd9 | 1 | 2025-01-14 |
| 0409-0009-25 | ML - Milliliter | 0409-0009 | 51dc31b2-eebb-4552-a828-a20daadf204d | 1 | 2025-01-14 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1740467 | ondansetron 4 MG in 2 ML Injection | PSN | d62cd60b-f87e-4825-bead-1d18bbc4e480 | 4 |
| 1740467 | 2 ML ondansetron 2 MG/ML Injection | SCD | d62cd60b-f87e-4825-bead-1d18bbc4e480 | 4 |
| 1740467 | ondansetron 4 MG per 2 ML Injection | SY | d62cd60b-f87e-4825-bead-1d18bbc4e480 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0409-0009-02 | 00409000902 | 2 mL in 1 VIAL, SINGLE-DOSE | 2 ml | Historical | |||
| 0409-0009-25 | 00409000925 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-0009-25) / 2 mL in 1 VIAL, SINGLE-DOSE (0409-0009-02) | 2024-12-16 | No | No | Current |